位于甲状腺峡部或上三分之一的乳头状甲状腺癌与Delphian淋巴结转移相关。

Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.

作者信息

Chai Young Jun, Kim Su-Jin, Choi June Young, Koo Do Hoon, Lee Kyu Eun, Youn Yeo-Kyu

机构信息

Department of Surgery, Seoul National University Hospital and College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea.

出版信息

World J Surg. 2014 Jun;38(6):1306-11. doi: 10.1007/s00268-013-2406-x.

Abstract

BACKGROUND

Delphian lymph node (DLN) metastasis is a recognized indicator of further lymph node involvement in papillary thyroid carcinoma (PTC). The aim of this study was to evaluate the clinicopathological significance of and risk factors for DLN metastasis.

METHODS

The medical records of 1,436 patients who underwent primary thyroidectomy for classical PTC with a tumor size of 2 cm or less were reviewed. Of these, 370 patients from whom the DLN was harvested were enrolled. Metastasis in DLN was present in 46 patients and absent in 324 patients. Clinicopathological features were compared according to DLN metastasis.

RESULTS

In univariate analysis, DLN metastasis was associated with suspected lymph node metastasis on preoperative ultrasonography, tumor location in the isthmus or upper third of the thyroid, larger tumor size, extrathyroid extension, lymphovascular invasion, and further lymph node metastasis. Multivariable analysis revealed that DLN metastasis was associated with tumor location in the isthmus or upper third of the thyroid (odds ratio [OR] = 2.420; 95 % confidence interval [CI] 1.193-4.910) and further lymph node metastasis (OR = 4.746; 95 % CI 2.065-10.908).

CONCLUSIONS

DLN metastasis in PTC is associated with tumor location in the isthmus or upper third of the thyroid and unfavorable clinicopathological characteristics. Careful consideration and patient management are warranted when preoperative ultrasonography indicates that the tumor is located in the isthmus or upper third of the thyroid.

摘要

背景

Delphian淋巴结(DLN)转移是甲状腺乳头状癌(PTC)中进一步出现淋巴结受累的公认指标。本研究的目的是评估DLN转移的临床病理意义及危险因素。

方法

回顾了1436例因肿瘤大小为2 cm或更小的经典PTC接受初次甲状腺切除术患者的病历。其中,370例切除DLN的患者被纳入研究。46例患者的DLN存在转移,324例患者的DLN无转移。根据DLN转移情况比较临床病理特征。

结果

单因素分析显示,DLN转移与术前超声怀疑淋巴结转移、肿瘤位于甲状腺峡部或上三分之一、肿瘤较大、甲状腺外侵犯、淋巴管侵犯及进一步的淋巴结转移相关。多因素分析显示,DLN转移与肿瘤位于甲状腺峡部或上三分之一(比值比[OR]=2.420;95%置信区间[CI] 1.193 - 4.910)及进一步的淋巴结转移(OR = 4.746;95% CI 2.065 - 10.908)相关。

结论

PTC中的DLN转移与肿瘤位于甲状腺峡部或上三分之一及不良的临床病理特征相关。当术前超声提示肿瘤位于甲状腺峡部或上三分之一时,需要仔细考虑并对患者进行妥善管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索